CD8A and neoplasm: The mice that rejected the tumor rechallenge exhibited a significant increase in both effector and central memory CD8 + T cells in the lymph nodes on day 90 (P = 0.001 and 0.005, respectively; n = 6 or 7, Supplementary Fig. 5e, f), indicating that this combination therapy resulted in the formation of effective systemic immunological memory62.